15564314	Insulin	Gershengorn MC	Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells.	Science	2004	102
18769445	Insulin	Cohen E	The insulin paradox: aging, proteotoxicity and neurodegeneration.	Nature reviews. Neuroscience	2008	94
19406747	Insulin	Zhao WQ	Insulin receptor dysfunction impairs cellular clearance of neurotoxic oligomeric a{beta}.	The Journal of biological chemistry	2009	47
21355045	Insulin	Zhang T	TDP-43 neurotoxicity and protein aggregation modulated by heat shock factor and insulin/IGF-1 signaling.	Human molecular genetics	2011	39
21494607	Insulin	Burridge PW	A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability.	PloS one	2011	129
15361882	Peptides	Fernandez-Escamilla AM	Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins.	Nature biotechnology	2004	333
15691826	Peptides	Furukawa Y	Amyotrophic lateral sclerosis mutations have the greatest destabilizing effect on the apo- and reduced form of SOD1, leading to unfolding and oxidative aggregation.	The Journal of biological chemistry	2005	83
18442979	Peptides	Apostolidou M	Structure of alpha-helical membrane-bound human islet amyloid polypeptide and its implications for membrane-mediated misfolding.	The Journal of biological chemistry	2008	69
19208933	Peptides	Abedini A	A role for helical intermediates in amyloid formation by natively unfolded polypeptides?	Physical biology	2009	60
19944699	Deuterium	Lewis HA	Structure and dynamics of NBD1 from CFTR characterized using crystallography and hydrogen/deuterium exchange mass spectrometry.	Journal of molecular biology	2010	53
17328689	Glucose	Mattson MP	Calcium and neurodegeneration.	Aging cell	2007	168
19026743	Glucose	Zhao WQ	Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease.	Biochimica et biophysica acta	2009	59
24103379	Glucose	Murray PS	Psychosis in Alzheimer's disease.	Biological psychiatry	2014	24
15326189	Copper	Arnesano F	The unusually stable quaternary structure of human Cu,Zn-superoxide dismutase 1 is controlled by both metal occupancy and disulfide status.	The Journal of biological chemistry	2004	76
17592131	Copper	Banci L	Metal-free superoxide dismutase forms soluble oligomers under physiological conditions: a possible general mechanism for familial ALS.	Proceedings of the National Academy of Sciences of the United States of America	2007	78
18552350	Copper	Furukawa Y	Complete loss of post-translational modifications triggers fibrillar aggregation of SOD1 in the familial form of amyotrophic lateral sclerosis.	The Journal of biological chemistry	2008	64
17287498	Chelating Agents	Xie Z	The inhalation anesthetic isoflurane induces a vicious cycle of apoptosis and amyloid beta-protein accumulation.	The Journal of neuroscience 	2007	78
17623039	Iron	Uversky VN	Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation.	Journal of neurochemistry	2007	134
19011085	Iron	Salazar J	Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease.	Proceedings of the National Academy of Sciences of the United States of America	2008	101
22306201	Iron	Poulsen HE	RNA modifications by oxidation: a novel disease mechanism?	Free radical biology & medicine	2012	39
22706697	Iron	Fan K	Magnetoferritin nanoparticles for targeting and visualizing tumour tissues.	Nature nanotechnology	2012	40
18650432	Water	Steiner H	Intramembrane proteolysis by gamma-secretase.	The Journal of biological chemistry	2008	61
21814823	Acetylcholine	Pevzner A	Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis.	Journal of neurology	2012	39
26865365	Adenosine Diphosphate	Radons J	The human HSP70 family of chaperones: where do we stand?	Cell stress & chaperones	2016	26
8093612	Adenosine Triphosphate	Jakob U	Small heat shock proteins are molecular chaperones.	The Journal of biological chemistry	1993	247
12198491	Adenosine Triphosphate	Bota DA	Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism.	Nature cell biology	2002	141
14740253	Adenosine Triphosphate	Wegele H	Hsp70 and Hsp90--a relay team for protein folding.	Reviews of physiology, biochemistry and pharmacology	2004	142
17360912	Adenosine Triphosphate	Thies E	Missorting of tau in neurons causes degeneration of synapses that can be rescued by the kinase MARK2/Par-1.	The Journal of neuroscience 	2007	85
18704197	Adenosine Triphosphate	Lo Bianco C	Hsp104 antagonizes alpha-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease.	The Journal of clinical investigation	2008	60
22323447	Adenosine Triphosphate	Bernstein SH	The mitochondrial ATP-dependent Lon protease: a novel target in lymphoma death mediated by the synthetic triterpenoid CDDO and its derivatives.	Blood	2012	32
22449631	Adenosine Triphosphate	Garrido C	The small heat shock proteins family: the long forgotten chaperones.	The international journal of biochemistry & cell biology	2012	48
22990239	Adenosine Triphosphate	Rampelt H	Metazoan Hsp70 machines use Hsp110 to power protein disaggregation.	The EMBO journal	2012	88
23737532	Adenosine Triphosphate	Mattoo RU	Hsp110 is a bona fide chaperone using ATP to unfold stable misfolded polypeptides and reciprocally collaborate with Hsp70 to solubilize protein aggregates.	The Journal of biological chemistry	2013	47
24760129	Adenosine Triphosphate	Mattoo RU	Molecular chaperones are nanomachines that catalytically unfold misfolded and alternatively folded proteins.	Cellular and molecular life sciences 	2014	22
24949977	Adenosine Triphosphate	Kirschke E	Glucocorticoid receptor function regulated by coordinated action of the Hsp90 and Hsp70 chaperone cycles.	Cell	2014	71
26097841	Adenosine Triphosphate	Finka A	Multi-layered molecular mechanisms of polypeptide holding, unfolding and disaggregation by HSP70/HSP110 chaperones.	Frontiers in molecular biosciences	2015	21
26300264	Adenosine Triphosphate	Gao X	Human Hsp70 Disaggregase Reverses Parkinson's-Linked α-Synuclein Amyloid Fibrils.	Molecular cell	2015	43
26436840	Adenosine Triphosphate	Poepsel S	Determinants of amyloid fibril degradation by the PDZ protease HTRA1.	Nature chemical biology	2015	19
26669444	Adenosine Triphosphate	Lokireddy S	cAMP-induced phosphorylation of 26S proteasomes on Rpn6/PSMD11 enhances their activity and the degradation of misfolded proteins.	Proceedings of the National Academy of Sciences of the United States of America	2015	22
26860875	Adenosine Triphosphate	Migdalska-Richards A	The relationship between glucocerebrosidase mutations and Parkinson disease.	Journal of neurochemistry	2016	15
27050154	Adenosine Triphosphate	Finka A	Experimental Milestones in the Discovery of Molecular Chaperones as Polypeptide Unfolding Enzymes.	Annual review of biochemistry	2016	12
27973707	Adenosine Triphosphate	Sluchanko NN	Moonlighting chaperone-like activity of the universal regulatory 14-3-3 proteins.	The FEBS journal	2017	9
14593166	Dopamine	Dawson TM	Molecular pathways of neurodegeneration in Parkinson's disease.	Science	2003	362
15502874	Dopamine	Shendelman S	DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation.	PLoS biology	2004	142
16227205	Dopamine	Zhou W	DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T alpha-synuclein toxicity.	The Journal of biological chemistry	2005	99
17904601	Dopamine	White LD	New and evolving concepts in the neurotoxicology of lead.	Toxicology and applied pharmacology	2007	75
19711116	Dopamine	Jellinger KA	Formation and development of Lewy pathology: a critical update.	Journal of neurology	2009	49
21712347	Dopamine	Decressac M	GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease.	Brain 	2011	43
22166436	Dopamine	Phani S	Neurodegeneration and inflammation in Parkinson's disease.	Parkinsonism & related disorders	2012	42
22319455	Dopamine	Butler EK	The mitochondrial chaperone protein TRAP1 mitigates α-Synuclein toxicity.	PLoS genetics	2012	36
23610405	Dopamine	Decressac M	TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity.	Proceedings of the National Academy of Sciences of the United States of America	2013	126
24082145	Dopamine	Janezic S	Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model.	Proceedings of the National Academy of Sciences of the United States of America	2013	51
26616211	Dopamine	Lindholm D	Current disease modifying approaches to treat Parkinson's disease.	Cellular and molecular life sciences 	2016	14
16341090	Cysteine	Adam AC	The Nfs1 interacting protein Isd11 has an essential role in Fe/S cluster biogenesis in mitochondria.	The EMBO journal	2006	70
18316367	Cysteine	Karch CM	A limited role for disulfide cross-linking in the aggregation of mutant SOD1 linked to familial amyotrophic lateral sclerosis.	The Journal of biological chemistry	2008	50
19299510	Cysteine	Wilcox KC	Modifications of superoxide dismutase (SOD1) in human erythrocytes: a possible role in amyotrophic lateral sclerosis.	The Journal of biological chemistry	2009	50
21820099	Cysteine	Nosková L	Mutations in DNAJC5, encoding cysteine-string protein alpha, cause autosomal-dominant adult-onset neuronal ceroid lipofuscinosis.	American journal of human genetics	2011	79
23649698	Cysteine	Monet-Leprêtre M	Abnormal recruitment of extracellular matrix proteins by excess Notch3 ECD: a new pathomechanism in CADASIL.	Brain 	2013	25
25326800	Cysteine	Zhang Z	Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease.	Nature medicine	2014	47
26170293	Cysteine	McGlinchey RP	Cysteine cathepsins are essential in lysosomal degradation of α-synuclein.	Proceedings of the National Academy of Sciences of the United States of America	2015	16
15579465	Glycosaminoglycans	Bhattacharya SK	Proteomics reveal Cochlin deposits associated with glaucomatous trabecular meshwork.	The Journal of biological chemistry	2005	66
19878627	Glycosaminoglycans	Markway BD	Enhanced chondrogenic differentiation of human bone marrow-derived mesenchymal stem cells in low oxygen environment micropellet cultures.	Cell transplantation	2010	41
9111868	Hyaluronic Acid	Naor D	CD44: structure, function, and association with the malignant process.	Advances in cancer research	1997	194
23827186	Hyaluronic Acid	Pedron S	Regulation of glioma cell phenotype in 3D matrices by hyaluronic acid.	Biomaterials	2013	32
18787018	Cycloheximide	Adams BD	Argonaute-2 expression is regulated by epidermal growth factor receptor and mitogen-activated protein kinase signaling and correlates with a transformed phenotype in breast cancer cells.	Endocrinology	2009	55
22306778	Cycloheximide	Parker SJ	Endogenous TDP-43 localized to stress granules can subsequently form protein aggregates.	Neurochemistry international	2012	47
9405613	Urea	Bullock AN	Thermodynamic stability of wild-type and mutant p53 core domain.	Proceedings of the National Academy of Sciences of the United States of America	1997	112
20957377	Ampicillin	Vingtdeux V	AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies.	Acta neuropathologica	2011	54
27001618	Ampicillin	Shah SA	Novel osmotin inhibits SREBP2 via the AdipoR1/AMPK/SIRT1 pathway to improve Alzheimer's disease neuropathological deficits.	Molecular psychiatry	2017	10
17074831	Polysaccharides	Ruddock LW	N-glycan processing in ER quality control.	Journal of cell science	2006	60
16403519	Oxygen	Zhou W	The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein.	Journal of molecular biology	2006	81
28467905	Oxygen	Ramdzan YM	Huntingtin Inclusions Trigger Cellular Quiescence, Deactivate Apoptosis, and Lead to Delayed Necrosis.	Cell reports	2017	8
19181854	Detergents	Rath A	Detergent binding explains anomalous SDS-PAGE migration of membrane proteins.	Proceedings of the National Academy of Sciences of the United States of America	2009	192
23824824	Detergents	Klasse PJ	Influences on trimerization and aggregation of soluble, cleaved HIV-1 SOSIP envelope glycoprotein.	Journal of virology	2013	44
25425650	Phospholipids	Grey M	Acceleration of α-synuclein aggregation by exosomes.	The Journal of biological chemistry	2015	40
10723795	Cholesterol	Janes PW	The role of lipid rafts in T cell antigen receptor (TCR) signalling.	Seminars in immunology	2000	92
16565714	Cholesterol	Bosco DA	Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization.	Nature chemical biology	2006	67
18653762	Cholesterol	Jin X	SNMP is a signaling component required for pheromone sensitivity in Drosophila.	Proceedings of the National Academy of Sciences of the United States of America	2008	64
20035627	Cholesterol	Salminen A	ER stress in Alzheimer's disease: a novel neuronal trigger for inflammation and Alzheimer's pathology.	Journal of neuroinflammation	2009	75
20739751	Cholesterol	Rashid ST	Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells.	The Journal of clinical investigation	2010	173
23296339	Cholesterol	Liu CC	Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy.	Nature reviews. Neurology	2013	318
24559670	Cholesterol	Kanekiyo T	ApoE and Aβ in Alzheimer's disease: accidental encounters or partners?	Neuron	2014	83
11744721	Triglycerides	Cole NB	Lipid droplet binding and oligomerization properties of the Parkinson's disease protein alpha-synuclein.	The Journal of biological chemistry	2002	103
26367797	Triglycerides	UK10K Consortium.	The UK10K project identifies rare variants in health and disease.	Nature	2015	181
10850706	Hydrogen	Boyington JC	Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand.	Nature	2000	117
16439141	Rotenone	Betarbet R	Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system.	Neurobiology of disease	2006	76
20512121	Antiviral Agents	Kao RY	Identification of influenza A nucleoprotein as an antiviral target.	Nature biotechnology	2010	64
15369821	Hydrogen Peroxide	Baas BJ	Homotropic cooperativity of monomeric cytochrome P450 3A4 in a nanoscale native bilayer environment.	Archives of biochemistry and biophysics	2004	75
21175372	Edetic Acid	Chen SY	A new isolation method of human limbal progenitor cells by maintaining close association with their niche cells.	Tissue engineering. Part C, Methods	2011	38
12177198	Glutathione	Sherer TB	An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.	The Journal of neuroscience 	2002	123
12892645	Glutathione	Lou MF	Redox regulation in the lens.	Progress in retinal and eye research	2003	90
17141510	Glutathione	Hoepken HH	Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6.	Neurobiology of disease	2007	59
17693254	Glutathione	Rajasekaran NS	Human alpha B-crystallin mutation causes oxido-reductive stress and protein aggregation cardiomyopathy in mice.	Cell	2007	136
26564470	Glutathione	Deas E	Alpha-Synuclein Oligomers Interact with Metal Ions to Induce Oxidative Stress and Neuronal Death in Parkinson's Disease.	Antioxidants & redox signaling	2016	23
26950115	Glutathione	Zeeshan HM	Endoplasmic Reticulum Stress and Associated ROS.	International journal of molecular sciences	2016	26
21726807	Nitric Oxide	Sarkar S	Complex inhibitory effects of nitric oxide on autophagy.	Molecular cell	2011	87
19050071	Phosphatidylinositols	Sun Q	Identification of Barkor as a mammalian autophagy-specific factor for Beclin 1 and class III phosphatidylinositol 3-kinase.	Proceedings of the National Academy of Sciences of the United States of America	2008	187
11069888	Sirolimus	Zhang H	Regulation of cellular growth by the Drosophila target of rapamycin dTOR.	Genes & development	2000	187
17331981	Sirolimus	Fujita E	Two endoplasmic reticulum-associated degradation (ERAD) systems for the novel variant of the mutant dysferlin: ubiquitin/proteasome ERAD(I) and autophagy/lysosome ERAD(II).	Human molecular genetics	2007	103
19197361	Sirolimus	Bastidas RJ	The protein kinase Tor1 regulates adhesin gene expression in Candida albicans.	PLoS pathogens	2009	52
20639871	Sirolimus	Gao C	Autophagy negatively regulates Wnt signalling by promoting Dishevelled degradation.	Nature cell biology	2010	118
20810185	Sirolimus	Rautou PE	Autophagy in liver diseases.	Journal of hepatology	2010	99
24059496	Sirolimus	Sarkar S	Regulation of autophagy by mTOR-dependent and mTOR-independent pathways: autophagy dysfunction in neurodegenerative diseases and therapeutic application of autophagy enhancers.	Biochemical Society transactions	2013	69
25791428	Sirolimus	Tang Z	mTor mediates tau localization and secretion: Implication for Alzheimer's disease.	Biochimica et biophysica acta	2015	19
14734542	Superoxides	Rakhit R	Monomeric Cu,Zn-superoxide dismutase is a common misfolding intermediate in the oxidation models of sporadic and familial amyotrophic lateral sclerosis.	The Journal of biological chemistry	2004	93
15758154	Superoxides	Vijayvergiya C	Mutant superoxide dismutase 1 forms aggregates in the brain mitochondrial matrix of amyotrophic lateral sclerosis mice.	The Journal of neuroscience 	2005	70
17208444	Superoxides	Shaw BF	How do ALS-associated mutations in superoxide dismutase 1 promote aggregation of the protein?	Trends in biochemical sciences	2007	68
18282652	Superoxides	Turner BJ	Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.	Progress in neurobiology	2008	153
18666828	Superoxides	Wang Q	Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival.	PLoS biology	2008	56
19171884	Superoxides	Wang J	Progressive aggregation despite chaperone associations of a mutant SOD1-YFP in transgenic mice that develop ALS.	Proceedings of the National Academy of Sciences of the United States of America	2009	54
19271992	Superoxides	Chattopadhyay M	Aggregation of copper-zinc superoxide dismutase in familial and sporadic ALS.	Antioxidants & redox signaling	2009	46
19483195	Superoxides	Prudencio M	Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease.	Human molecular genetics	2009	63
20644736	Superoxides	Forsberg K	Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients.	PloS one	2010	89
21706386	Superoxides	Joyce PI	SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments.	Mammalian genome 	2011	37
21857683	Superoxides	Deng HX	Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia.	Nature	2011	264
22028219	Superoxides	Jucker M	Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders.	Annals of neurology	2011	153
22431618	Superoxides	Brotherton TE	Localization of a toxic form of superoxide dismutase 1 protein to pathologically affected tissues in familial ALS.	Proceedings of the National Academy of Sciences of the United States of America	2012	34
22967507	Superoxides	Weisberg SJ	Compartmentalization of superoxide dismutase 1 (SOD1G93A) aggregates determines their toxicity.	Proceedings of the National Academy of Sciences of the United States of America	2012	38
27064076	Superoxides	Parakh S	Protein folding alterations in amyotrophic lateral sclerosis.	Brain research	2016	12
27140399	Superoxides	Bidhendi EE	Two superoxide dismutase prion strains transmit amyotrophic lateral sclerosis-like disease.	The Journal of clinical investigation	2016	10
25667085	Antioxidants	Picone P	Metformin increases APP expression and processing via oxidative stress, mitochondrial dysfunction and NF-κB activation: Use of insulin to attenuate metformin's effect.	Biochimica et biophysica acta	2015	16
27561233	Antioxidants	Vij N	Nano-based rescue of dysfunctional autophagy in chronic obstructive lung diseases.	Expert opinion on drug delivery	2017	7
10364548	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Shi SH	Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation.	Science	1999	292
11466413	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Perez JL	PICK1 targets activated protein kinase Calpha to AMPA receptor clusters in spines of hippocampal neurons and reduces surface levels of the AMPA-type glutamate receptor subunit 2.	The Journal of neuroscience 	2001	101
23999428	Tacrolimus	Blair LJ	Accelerated neurodegeneration through chaperone-mediated oligomerization of tau.	The Journal of clinical investigation	2013	42
23616621	Phosphatidylserines	New SE	Macrophage-derived matrix vesicles: an alternative novel mechanism for microcalcification in atherosclerotic plaques.	Circulation research	2013	67
23435942	Cholinesterase Inhibitors	Anand P	A review on cholinesterase inhibitors for Alzheimer's disease.	Archives of pharmacal research	2013	33
17127365	Reactive Oxygen Species	Mancuso C	Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders.	Frontiers in bioscience 	2007	70
19715758	Reactive Oxygen Species	Gibson GE	Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases.	Biochimica et biophysica acta	2010	64
20385539	Reactive Oxygen Species	Chu CT	A pivotal role for PINK1 and autophagy in mitochondrial quality control: implications for Parkinson disease.	Human molecular genetics	2010	52
22411934	Reactive Oxygen Species	Salminen A	Inflammaging: disturbed interplay between autophagy and inflammasomes.	Aging	2012	79
25416158	Reactive Oxygen Species	Harischandra DS	α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson's disease.	Toxicological sciences 	2015	22
22301916	Cyclic AMP	Pimenta de Castro I	Genetic analysis of mitochondrial protein misfolding in Drosophila melanogaster.	Cell death and differentiation	2012	44
28031489	Cyclic AMP	Truttmann MC	Unrestrained AMPylation targets cytosolic chaperones and activates the heat shock response.	Proceedings of the National Academy of Sciences of the United States of America	2017	6
15722360	Fluorescent Dyes	Demuro A	Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers.	The Journal of biological chemistry	2005	244
11406612	geldanamycin	Sittler A	Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington's disease.	Human molecular genetics	2001	101
14962978	geldanamycin	Petrucelli L	CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation.	Human molecular genetics	2004	175
2195544	Islet Amyloid Polypeptide	Westermark P	Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation.	Proceedings of the National Academy of Sciences of the United States of America	1990	160
10078548	Islet Amyloid Polypeptide	Janson J	The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles.	Diabetes	1999	156
15292279	Islet Amyloid Polypeptide	Hull RL	Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes.	The Journal of clinical endocrinology and metabolism	2004	128
16142909	Islet Amyloid Polypeptide	Jayasinghe SA	Lipid membranes modulate the structure of islet amyloid polypeptide.	Biochemistry	2005	88
19244249	Islet Amyloid Polypeptide	Patil SM	Dynamic alpha-helix structure of micelle-bound human amylin.	The Journal of biological chemistry	2009	53
19346479	Islet Amyloid Polypeptide	Shim SH	Two-dimensional IR spectroscopy and isotope labeling defines the pathway of amyloid formation with residue-specific resolution.	Proceedings of the National Academy of Sciences of the United States of America	2009	93
21723249	Islet Amyloid Polypeptide	Nanga RP	Structure and membrane orientation of IAPP in its natively amidated form at physiological pH in a membrane environment.	Biochimica et biophysica acta	2011	50
21818468	Islet Amyloid Polypeptide	DeToma AS	Misfolded proteins in Alzheimer's disease and type II diabetes.	Chemical Society reviews	2012	55
21916515	Islet Amyloid Polypeptide	Wang L	2DIR spectroscopy of human amylin fibrils reflects stable β-sheet structure.	Journal of the American Chemical Society	2011	37
21942864	Islet Amyloid Polypeptide	Brender JR	Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective.	Accounts of chemical research	2012	71
24218609	Islet Amyloid Polypeptide	Buchanan LE	Mechanism of IAPP amyloid fibril formation involves an intermediate with a transient β-sheet.	Proceedings of the National Academy of Sciences of the United States of America	2013	41
25515893	Islet Amyloid Polypeptide	Young LM	Screening and classifying small-molecule inhibitors of amyloid formation using ion mobility spectrometry-mass spectrometry.	Nature chemistry	2015	28
25937088	Islet Amyloid Polypeptide	Vaikath NN	Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology.	Neurobiology of disease	2015	19
25998900	Islet Amyloid Polypeptide	Mukherjee A	Type 2 diabetes as a protein misfolding disease.	Trends in molecular medicine	2015	25
26649319	Islet Amyloid Polypeptide	Akter R	Islet Amyloid Polypeptide: Structure, Function, and Pathophysiology.	Journal of diabetes research	2016	11
9292723	polyglutamine	Paulson HL	Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3.	Neuron	1997	139
9620770	polyglutamine	Cummings CJ	Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1.	Nature genetics	1998	178
10200309	polyglutamine	Scherzinger E	Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology.	Proceedings of the National Academy of Sciences of the United States of America	1999	168
10581028	polyglutamine	Warrick JM	Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70.	Nature genetics	1999	215
11359930	polyglutamine	Waelter S	Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation.	Molecular biology of the cell	2001	161
11978772	polyglutamine	Wyttenbach A	Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin.	Human molecular genetics	2002	109
12360295	polyglutamine	Kim S	Polyglutamine protein aggregates are dynamic.	Nature cell biology	2002	89
12651870	polyglutamine	Taylor JP	Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein.	Human molecular genetics	2003	119
12747895	polyglutamine	Bates G	Huntingtin aggregation and toxicity in Huntington's disease.	Lancet	2003	106
14978262	polyglutamine	Lee WC	Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease.	Proceedings of the National Academy of Sciences of the United States of America	2004	99
15664989	polyglutamine	Jana NR	Co-chaperone CHIP associates with expanded polyglutamine protein and promotes their degradation by proteasomes.	The Journal of biological chemistry	2005	84
15806102	polyglutamine	Giorgini F	A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease.	Nature genetics	2005	100
16192271	polyglutamine	Iwata A	HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin.	The Journal of biological chemistry	2005	230
16624810	polyglutamine	Ellisdon AM	The two-stage pathway of ataxin-3 fibrillogenesis involves a polyglutamine-independent step.	The Journal of biological chemistry	2006	68
16980958	polyglutamine	Kitamura A	Cytosolic chaperonin prevents polyglutamine toxicity with altering the aggregation state.	Nature cell biology	2006	105
16980959	polyglutamine	Tam S	The chaperonin TRiC controls polyglutamine aggregation and toxicity through subunit-specific interactions.	Nature cell biology	2006	112
17118264	polyglutamine	Williams A	Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications.	Current topics in developmental biology	2006	109
18006506	polyglutamine	Carra S	HspB8 chaperone activity toward poly(Q)-containing proteins depends on its association with Bag3, a stimulator of macroautophagy.	The Journal of biological chemistry	2008	91
18434538	polyglutamine	Johnson BS	A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity.	Proceedings of the National Academy of Sciences of the United States of America	2008	156
18466116	polyglutamine	Imarisio S	Huntington's disease: from pathology and genetics to potential therapies.	The Biochemical journal	2008	113
19270701	polyglutamine	Thakur AK	Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism.	Nature structural & molecular biology	2009	134
19710014	polyglutamine	Aiken CT	Phosphorylation of threonine 3: implications for Huntingtin aggregation and neurotoxicity.	The Journal of biological chemistry	2009	50
19910924	polyglutamine	Fiesel FC	Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6.	The EMBO journal	2010	90
19915590	polyglutamine	Tam S	The chaperonin TRiC blocks a huntingtin sequence element that promotes the conformational switch to aggregation.	Nature structural & molecular biology	2009	90
20018885	polyglutamine	Pankiv S	Nucleocytoplasmic shuttling of p62/SQSTM1 and its role in recruitment of nuclear polyubiquitinated proteins to promyelocytic leukemia bodies.	The Journal of biological chemistry	2010	60
20026071	polyglutamine	Williamson TE	Modulation of polyglutamine conformations and dimer formation by the N-terminus of huntingtin.	Journal of molecular biology	2010	48
20159555	polyglutamine	Hageman J	A DNAJB chaperone subfamily with HDAC-dependent activities suppresses toxic protein aggregation.	Molecular cell	2010	84
20444706	polyglutamine	Olshina MA	Tracking mutant huntingtin aggregation kinetics in cells reveals three major populations that include an invariant oligomer pool.	The Journal of biological chemistry	2010	40
20554523	polyglutamine	Fuentealba RA	Interaction with polyglutamine aggregates reveals a Q/N-rich domain in TDP-43.	The Journal of biological chemistry	2010	64
20685997	polyglutamine	Miller J	Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into huntington's disease molecular pathogenesis.	The Journal of neuroscience 	2010	42
20843828	polyglutamine	Vos MJ	HSPB7 is the most potent polyQ aggregation suppressor within the HSPB family of molecular chaperones.	Human molecular genetics	2010	47
21163446	polyglutamine	Ross CA	Huntington's disease: from molecular pathogenesis to clinical treatment.	The Lancet. Neurology	2011	293
21183075	polyglutamine	Fiumara F	Essential role of coiled coils for aggregation and activity of Q/N-rich prions and PolyQ proteins.	Cell	2010	66
21189122	polyglutamine	Vidal R	Converging pathways in the occurrence of endoplasmic reticulum (ER) stress in Huntington's disease.	Current molecular medicine	2011	42
21231916	polyglutamine	Hageman J	The diverse members of the mammalian HSP70 machine show distinct chaperone-like activities.	The Biochemical journal	2011	48
22113611	polyglutamine	Koch P	Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease.	Nature	2011	80
22178474	polyglutamine	Jayaraman M	Slow amyloid nucleation via α-helix-rich oligomeric intermediates in short polyglutamine-containing huntingtin fragments.	Journal of molecular biology	2012	46
22306404	polyglutamine	Wetzel R	Physical chemistry of polyglutamine: intriguing tales of a monotonous sequence.	Journal of molecular biology	2012	59
22433867	polyglutamine	Nucifora LG	Identification of novel potentially toxic oligomers formed in vitro from mammalian-derived expanded huntingtin exon-1 protein.	The Journal of biological chemistry	2012	34
22684686	polyglutamine	Seidel K	Brain pathology of spinocerebellar ataxias.	Acta neuropathologica	2012	53
22927396	polyglutamine	van der Goot AT	Delaying aging and the aging-associated decline in protein homeostasis by inhibition of tryptophan degradation.	Proceedings of the National Academy of Sciences of the United States of America	2012	34
23222885	polyglutamine	Wang AM	Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation.	Nature chemical biology	2013	58
23612975	polyglutamine	Gillis J	The DNAJB6 and DNAJB8 protein chaperones prevent intracellular aggregation of polyglutamine peptides.	The Journal of biological chemistry	2013	27
23768628	polyglutamine	Labbadia J	Huntington's disease: underlying molecular mechanisms and emerging concepts.	Trends in biochemical sciences	2013	58
23791384	polyglutamine	Park SH	PolyQ proteins interfere with nuclear degradation of cytosolic proteins by sequestering the Sis1p chaperone.	Cell	2013	103
23873212	polyglutamine	Tsvetkov AS	Proteostasis of polyglutamine varies among neurons and predicts neurodegeneration.	Nature chemical biology	2013	45
24282292	polyglutamine	Crick SL	Unmasking the roles of N- and C-terminal flanking sequences from exon 1 of huntingtin as modulators of polyglutamine aggregation.	Proceedings of the National Academy of Sciences of the United States of America	2013	47
24840975	polyglutamine	Deng H	The role of FUS gene variants in neurodegenerative diseases.	Nature reviews. Neurology	2014	36
25280367	polyglutamine	Hoop CL	Polyglutamine amyloid core boundaries and flanking domain dynamics in huntingtin fragment fibrils determined by solid-state nuclear magnetic resonance.	Biochemistry	2014	20
25282404	polyglutamine	Martin DD	Autophagy in Huntington disease and huntingtin in autophagy.	Trends in neurosciences	2015	42
25437566	polyglutamine	Brehme M	A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease.	Cell reports	2014	69
26590344	polyglutamine	Bañez-Coronel M	RAN Translation in Huntington Disease.	Neuron	2015	39
27106072	polyglutamine	Kampinga HH	Heat shock proteins as potential targets for protective strategies in neurodegeneration.	The Lancet. Neurology	2016	11
27188817	polyglutamine	Bates GP	Huntington disease.	Nature reviews. Disease primers	2015	54
7593197	herbimycin	Miyamoto S	Integrin function: molecular hierarchies of cytoskeletal and signaling molecules.	The Journal of cell biology	1995	239
10978169	Amyloid beta-Peptides	Walsh DM	The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain.	Biochemistry	2000	118
17046788	Amyloid beta-Peptides	Yan Y	Abeta42 is more rigid than Abeta40 at the C terminus: implications for Abeta aggregation and toxicity.	Journal of molecular biology	2006	64
18359102	Amyloid beta-Peptides	Selkoe DJ	Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior.	Behavioural brain research	2008	318
18673201	Amyloid beta-Peptides	Deane R	The role of the cell surface LRP and soluble LRP in blood-brain barrier Abeta clearance in Alzheimer's disease.	Current pharmaceutical design	2008	58
23898162	Heparan Sulfate Proteoglycans	Holmes BB	Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds.	Proceedings of the National Academy of Sciences of the United States of America	2013	115
22035455	donepezil	Salomone S	New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs.	British journal of clinical pharmacology	2012	54
8453378	thioflavin T	LeVine H 3rd	Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution.	Protein science 	1993	332
12217698	thioflavin T	Hoyer W	Dependence of alpha-synuclein aggregate morphology on solution conditions.	Journal of molecular biology	2002	100
14729357	thioflavin T	Anderson DH	Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration.	Experimental eye research	2004	88
16973602	thioflavin T	Evans CG	Heat shock proteins 70 and 90 inhibit early stages of amyloid beta-(1-42) aggregation in vitro.	The Journal of biological chemistry	2006	98
16982417	thioflavin T	Mueller-Steiner S	Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease.	Neuron	2006	104
20111867	thioflavin T	Kerman A	Amyotrophic lateral sclerosis is a non-amyloid disease in which extensive misfolding of SOD1 is unique to the familial form.	Acta neuropathologica	2010	54
21427723	thioflavin T	Cohen TJ	The acetylation of tau inhibits its function and promotes pathological tau aggregation.	Nature communications	2011	113
21451522	thioflavin T	Alavez S	Amyloid-binding compounds maintain protein homeostasis during ageing and extend lifespan.	Nature	2011	92
21613474	thioflavin T	Waxman EA	Induction of intracellular tau aggregation is promoted by α-synuclein seeds and provides novel insights into the hyperphosphorylation of tau.	The Journal of neuroscience 	2011	44
22715097	thioflavin T	Ano Bom AP	Mutant p53 aggregates into prion-like amyloid oligomers and fibrils: implications for cancer.	The Journal of biological chemistry	2012	44
22908252	thioflavin T	Yoshimura Y	Distinguishing crystal-like amyloid fibrils and glass-like amorphous aggregates from their kinetics of formation.	Proceedings of the National Academy of Sciences of the United States of America	2012	40
25217638	thioflavin T	Månsson C	Interaction of the molecular chaperone DNAJB6 with growing amyloid-beta 42 (Aβ42) aggregates leads to sub-stoichiometric inhibition of amyloid formation.	The Journal of biological chemistry	2014	28
25253695	thioflavin T	Benilova I	The Alzheimer disease protective mutation A2T modulates kinetic and thermodynamic properties of amyloid-β (Aβ) aggregation.	The Journal of biological chemistry	2014	30
16893904	epigallocatechin gallate	Ehrnhoefer DE	Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models.	Human molecular genetics	2006	81
18511942	epigallocatechin gallate	Ehrnhoefer DE	EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers.	Nature structural & molecular biology	2008	225
23611538	epigallocatechin gallate	Palhano FL	Toward the molecular mechanism(s) by which EGCG treatment remodels mature amyloid fibrils.	Journal of the American Chemical Society	2013	42
11889467	polyalanine	Strømme P	Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy.	Nature genetics	2002	85
23509976	Curcumin	Singh PK	Curcumin modulates α-synuclein aggregation and toxicity.	ACS chemical neuroscience	2013	30
22689910	Trehalose	Schaeffer V	Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy.	Brain 	2012	64
19717454	malic acid	Jaya N	Substrate binding site flexibility of the small heat shock protein molecular chaperones.	Proceedings of the National Academy of Sciences of the United States of America	2009	73
26627475	malic acid	Bezawork-Geleta A	LON is the master protease that protects against protein aggregation in human mitochondria through direct degradation of misfolded proteins.	Scientific reports	2015	15
24548101	aminochrome 1	Segura-Aguilar J	Protective and toxic roles of dopamine in Parkinson's disease.	Journal of neurochemistry	2014	31
20947801	Trifluoroethanol	Anderson VL	Identification of a helical intermediate in trifluoroethanol-induced alpha-synuclein aggregation.	Proceedings of the National Academy of Sciences of the United States of America	2010	50
25691742	trimethyloxamine	Levine ZA	Regulation and aggregation of intrinsically disordered peptides.	Proceedings of the National Academy of Sciences of the United States of America	2015	18
15845543	beta-hexachlorocyclohexane	Shin Y	The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates alpha-synuclein degradation decisions between proteasomal and lysosomal pathways.	The Journal of biological chemistry	2005	85
18070888	beta-hexachlorocyclohexane	Rott R	Monoubiquitylation of alpha-synuclein by seven in absentia homolog (SIAH) promotes its aggregation in dopaminergic cells.	The Journal of biological chemistry	2008	52
20203178	beta-hexachlorocyclohexane	Paleologou KE	Phosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization, and influences synuclein-membrane interactions.	The Journal of neuroscience 	2010	72
20505094	beta-hexachlorocyclohexane	Clinton LK	Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline.	The Journal of neuroscience 	2010	101
21571086	beta-hexachlorocyclohexane	Moreno-Gonzalez I	Misfolded protein aggregates: mechanisms, structures and potential for disease transmission.	Seminars in cell & developmental biology	2011	42
11772336	tanespimycin	Maloney A	HSP90 as a new therapeutic target for cancer therapy: the story unfolds.	Expert opinion on biological therapy	2002	91
21478269	tanespimycin	Li D	Functional inactivation of endogenous MDM2 and CHIP by HSP90 causes aberrant stabilization of mutant p53 in human cancer cells.	Molecular cancer research 	2011	68
18548070	4-azidophenylpropionamide	Kukar TL	Substrate-targeting gamma-secretase modulators.	Nature	2008	105
26769963	Alanine	Chang YJ	The Glycine-Alanine Dipeptide Repeat from C9orf72 Hexanucleotide Expansions Forms Toxic Amyloids Possessing Cell-to-Cell Transmission Properties.	The Journal of biological chemistry	2016	12
16807295	Amino Acids	Jäger M	Structure-function-folding relationship in a WW domain.	Proceedings of the National Academy of Sciences of the United States of America	2006	73
28261941	Amino Acids	Takahashi RH	Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease.	Pathology international	2017	10
28389532	Amino Acids	Harrison AF	RNA-binding proteins with prion-like domains in health and disease.	The Biochemical journal	2017	11
10225955	valyl-prolyl-proline	Takahashi K	Nectin/PRR: an immunoglobulin-like cell adhesion molecule recruited to cadherin-based adherens junctions through interaction with Afadin, a PDZ domain-containing protein.	The Journal of cell biology	1999	133
18199773	valyl-prolyl-proline	Mocanu MM	The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy.	The Journal of neuroscience 	2008	75
21889356	valyl-prolyl-proline	Storer CL	FKBP51 and FKBP52 in signaling and disease.	Trends in endocrinology and metabolism	2011	49
16505168	Glycine	Levy JR	A motor neuron disease-associated mutation in p150Glued perturbs dynactin function and induces protein aggregation.	The Journal of cell biology	2006	62
24268778	Glycine	Schwartz JC	RNA seeds higher-order assembly of FUS protein.	Cell reports	2013	54
17360908	beta-amyloid peptide 1-42 (E22delta) click peptide	Shankar GM	Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway.	The Journal of neuroscience 	2007	469
17553989	beta-amyloid peptide 1-42 (E22delta) click peptide	Klunk WE	Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees.	The Journal of neuroscience 	2007	117
19339974	beta-amyloid peptide 1-42 (E22delta) click peptide	Bu G	Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy.	Nature reviews. Neuroscience	2009	264
19465477	beta-amyloid peptide 1-42 (E22delta) click peptide	Johnson BS	TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity.	The Journal of biological chemistry	2009	198
19815015	beta-amyloid peptide 1-42 (E22delta) click peptide	Hampel H	Biological markers of amyloid beta-related mechanisms in Alzheimer's disease.	Experimental neurology	2010	45
20713699	beta-amyloid peptide 1-42 (E22delta) click peptide	Sandberg A	Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering.	Proceedings of the National Academy of Sciences of the United States of America	2010	83
21846727	beta-amyloid peptide 1-42 (E22delta) click peptide	Emmer KL	E46K human alpha-synuclein transgenic mice develop Lewy-like and tau pathology associated with age-dependent, detrimental motor impairment.	The Journal of biological chemistry	2011	38
22179788	beta-amyloid peptide 1-42 (E22delta) click peptide	Narayan P	The extracellular chaperone clusterin sequesters oligomeric forms of the amyloid-β(1-40) peptide.	Nature structural & molecular biology	2011	68
23132858	beta-amyloid peptide 1-42 (E22delta) click peptide	Li J	Differential regulation of amyloid-β endocytic trafficking and lysosomal degradation by apolipoprotein E isoforms.	The Journal of biological chemistry	2012	45
23703910	beta-amyloid peptide 1-42 (E22delta) click peptide	Cohen SI	Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism.	Proceedings of the National Academy of Sciences of the United States of America	2013	170
11375494	thymosin beta(1)	Bence NF	Impairment of the ubiquitin-proteasome system by protein aggregation.	Science	2001	521
16807328	thymosin beta(1)	Dickey CA	Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau species.	The Journal of neuroscience 	2006	81
16874037	thymosin beta(1)	Bjørkøy G	p62/SQSTM1: a missing link between protein aggregates and the autophagy machinery.	Autophagy	2006	92
19250912	thymosin beta(1)	Korolchuk VI	Autophagy inhibition compromises degradation of ubiquitin-proteasome pathway substrates.	Molecular cell	2009	237
19696071	thymosin beta(1)	Su H	The ubiquitin-proteasome system in cardiac proteinopathy: a quality control perspective.	Cardiovascular research	2010	45
23178947	thymosin beta(1)	Korac J	Ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates.	Journal of cell science	2013	64
22645360	tafamidis	Bulawa CE	Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade.	Proceedings of the National Academy of Sciences of the United States of America	2012	109
17702753	cholecystokinin C-terminal flanking peptide	Li Z	Mapping the interacting domains of STIM1 and Orai1 in Ca2+ release-activated Ca2+ channel activation.	The Journal of biological chemistry	2007	106
20064390	cholecystokinin C-terminal flanking peptide	Gu X	Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice.	Neuron	2009	117
18756251	poly(gamma-methylglutamate)-grafted polyallylamine	Kaganovich D	Misfolded proteins partition between two distinct quality control compartments.	Nature	2008	289
21454603	sarkosyl	Furukawa Y	A seeding reaction recapitulates intracellular formation of Sarkosyl-insoluble transactivation response element (TAR) DNA-binding protein-43 inclusions.	The Journal of biological chemistry	2011	64
22496370	sarkosyl	Santa-Maria I	Paired helical filaments from Alzheimer disease brain induce intracellular accumulation of Tau protein in aggresomes.	The Journal of biological chemistry	2012	30
